Foresee Pharmaceuticals Co Ltd Capital Reinvestment Ratio

Latest as of June 2022: 0.00x

Foresee Pharmaceuticals Co Ltd capital reinvestment ratio. Foresee Pharmaceuticals Co Ltd (6576) has a Capital Reinvestment Ratio of 0.00x as of June 2022, meaning it reinvests 0% of its operating cash flow (NT$143.03 Million) in capital expenditures (NT$590.00K). Check 6576 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.00x

Capex / Operating Cash Flow

Operating Cash Flow

NT$143.03 Million

TWD

Capital Expenditures

NT$590.00K

TWD

Data as of

Jun 2022

Most recent filing

Foresee Pharmaceuticals Co Ltd Capital Reinvestment Ratio by Year (None–None)

Foresee Pharmaceuticals Co Ltd capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see 6576 operating cash flow.

Year	Reinvestment Ratio	Operating CF (TWD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow